Medicare AdvantageCoverageMedium impact
MA06.019c, Measurement of Serum Antibodies to and Measurement of Serum Levels of Biologics
Independence Blue Cross·Rheumatology, Gastroenterology, Dermatology +1 more·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.019c regarding measurement of serum antibodies and serum levels of biologics has been reissued and is now effective. This policy likely affects coverage criteria and billing requirements for laboratory tests related to biologic medications and antibody testing.
Action Required
By October 1, 2025: Billing team should review the complete policy document at the provided URL to understand specific coverage criteria and documentation requirements for serum antibody testing and biologic level monitoring. Update billing procedures and prior authorization workflows as needed based on the full policy content.